Page 2 - Tissue Matrix News Today

TELA Bio (NASDAQ:TELA – Get Rating) and Utah Medical Products (NASDAQ:UTMD – Get Rating) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, valuation, earnings, risk and analyst recommendations. Profitability This table compares TELA Bio and Utah […]

TELA Bio, Inc. (NASDAQ:TELA – Get Rating) was the recipient of a significant growth in short interest in May. As of May 15th, there was short interest totalling 53,200 shares, a growth of 33.7% from the April 30th total of 39,800 shares. Based on an average trading volume of 59,400 shares, the short-interest ratio is […]

TELA Bio, Inc. (NASDAQ:TELA – Get Rating) saw a significant decline in short interest in the month of April. As of April 30th, there was short interest totalling 39,800 shares, a decline of 64.7% from the April 15th total of 112,700 shares. Based on an average daily volume of 53,300 shares, the short-interest ratio is […]

TELA Bio (NASDAQ:TELA – Get Rating) and MiMedx Group (NASDAQ:MDXG – Get Rating) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, analyst recommendations, institutional ownership, risk, valuation, dividends and profitability. Analyst Ratings This is a summary of recent recommendations […]

Canaccord Genuity Group reiterated their buy rating on shares of TELA Bio (NASDAQ:TELA – Get Rating) in a research note issued to investors on Tuesday, Benzinga reports. The firm currently has a $15.00 price target on the stock. Separately, JMP Securities restated a market outperform rating and set a $20.00 price target on shares of […]

Canaccord Genuity Group restated their buy rating on shares of TELA Bio (NASDAQ:TELA – Get Rating) in a report released on Tuesday, Benzinga reports. Canaccord Genuity Group currently has a $15.00 target price on the stock. Separately, JMP Securities reaffirmed a market outperform rating and set a $20.00 price objective on shares of TELA Bio […]

Canaccord Genuity Group reaffirmed their buy rating on shares of TELA Bio (NASDAQ:TELA – Get Rating) in a research note published on Tuesday, Benzinga reports. The firm currently has a $15.00 price target on the stock. Separately, JMP Securities restated a market outperform rating and issued a $20.00 price objective on shares of TELA Bio […]

TELA Bio, Inc. (NASDAQ:TELA – Get Rating) – Analysts at Jefferies Financial Group issued their Q1 2023 earnings per share estimates for TELA Bio in a research report issued to clients and investors on Tuesday, March 21st. Jefferies Financial Group analyst M. Sarcone expects that the company will post earnings per share of ($0.53) for […]

TELA Bio, Inc. (NASDAQ:TELA – Get Rating) – Analysts at Jefferies Financial Group issued their Q4 2023 EPS estimates for shares of TELA Bio in a report issued on Tuesday, March 21st. Jefferies Financial Group analyst M. Sarcone anticipates that the company will post earnings of ($0.50) per share for the quarter. The consensus estimate […]

MALVERN, Pa., March 21, 2023 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio"), a commercial-stage medical technology company focused on providing...